Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
Many vaccine candidates with promising results in preclinical testing fail in human trials. New complex human tissue models have the potential to improve the predictability of vaccine safety and efficacy in human clinical trials.
Enregistré dans:
Auteurs principaux: | David Komla Kessie, Thomas Rudel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3e9a2bb220b045d4ae6e75a8ae2950f2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research
par: Susann Haehnel, et autres
Publié: (2019) -
Preclinical Advances of Therapies for Laminopathies
par: Louise Benarroch, et autres
Publié: (2021) -
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans
par: Kelly E. Seaton, et autres
Publié: (2021) -
Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
par: Nan Li, et autres
Publié: (2021) -
Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
par: M. Tarek Elghetany, et autres
Publié: (2021)